Innovation that Raises the Bar

We’re integrating historically distinct areas of expertise and technology into a unified knowledge platform, improving how we collect, analyse and apply data to spark insights that can improve patients’ lives. 

We’re using advanced technologies to help advance medicines and leveraging deep understanding of disease mechanisms to target the right patient with the right medicine at the right time. 

Through one of the largest genomics research efforts in the world, our goal is to build a greater understanding of disease biology and human data to better inform critical decisions in the journey to create medicines.

From partnering with patients to advance drug development to diversifying our clinical trials to harnessing real-world data, our scientists use novel approaches that apply patient insights to deliver products and solutions for conditions with great unmet need. 

We turn to our R&D toolbox — a mix of traditional and cutting-edge modalities — to create the best compound for a specific target. These modalities include gene and cell therapies, antibody-drug conjugates, targeted protein degraders and more.

From early experimental work to progressing late-stage programs, we use advanced technologies end-to-end across R&D, including artificial intelligence and machine learning, genetic medicine delivery, cell generation therapies and more.